BIOHARVEST SCIENCES INC.

BioHarvest Sciences Inc. is a biotechnology company that develops plant cell cultivation technology to produce botanical extracts with elevated concentrations of bioactive compounds. The company operates through two primary segments: Nutraceuticals and Pharmaceuticals. Its core technology platform enables the synthesis of plant cells for use in dietary supplements, functional foods, and cosmeceutical products, positioning the company as both a product manufacturer and contract development and manufacturing operations (CDMO) service provider.

The company's commercial product portfolio includes VINIA, a dietary supplement derived from red grape cells that contains polyphenols. Beyond its branded products, BioHarvest generates revenue through contract manufacturing services for third parties seeking to leverage its botanical synthesis capabilities. The company maintains operations in Israel and the United States, with corporate headquarters in Vancouver, British Columbia.

As a micro-cap public company listed on Nasdaq, BioHarvest operates at a relatively small scale within the nutraceutical and specialty pharmaceutical industries. The company is incorporated in British Columbia and serves both the dietary supplement market, which is regulated as food, and the pharmaceutical sector, reflecting its dual business focus.